Business Context and Reporting Period
This Form 8-K was filed by iSpecimen Inc. (ISPC) on July 9, 2025. The company is incorporated in Delaware and operates as an emerging growth company. The report details a corporate governance amendment effective as of the filing date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a change to the company's Bylaws and does not contain financial performance data.
Material Changes
On July 9, 2025, the Company amended its Second Amended and Restated Bylaws to modify the quorum requirement for shareholder meetings. The amendment reduced the quorum threshold from a majority of the voting power of outstanding shares entitled to vote to 34% of such voting power.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the procedural update regarding the Bylaws amendment.
Key Facts for Investor Verification
- The quorum requirement for shareholder meetings has been lowered to 34% of voting power.
- The amendment was approved and effective as of July 9, 2025.
- The Third Amended and Restated Bylaws are filed as Exhibit 3.1.
- The company remains classified as an emerging growth company.